Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...

UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Deutsche Bank (ETR:DBKGn) analyst Benjamin Goy upgraded UBS AG (UBSG:SW) (NYSE: UBS) stock rating from Hold to Buy and increased the price target from CHF29.00 to CHF37.00. Goy noted that UBS's share ...

Switzerland could also be targeted by the new US President Donald Trump. According to a study by the major bank UBS, the pharmaceutical industry in ...

Stocks in Asia are set to advance after US traders looked past concerns over tariff threats and toward Federal Reserve comments and inflation data. The dollar strengthened and gold hit a record.

UBS should have more clarity on the amount of capital it will need to hold under new Swiss banking regulations currently ...